NCT06519526
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
Clinical trial condition
Relapsed/Refractory Peripheral T Cell Lymphoma
Explore clinical trials studying Relapsed/Refractory Peripheral T Cell Lymphoma. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
Relapsed/Refractory Peripheral T Cell Lymphoma trial results
NCT06776952
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Beijing Friendship Hospital,Capital Medical University Beijing, Beijing Municipality, China
Not Yet Recruiting
To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma
NCT06702605
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified